Akèy › Kansè poumon selil ti › Ohio › Cleveland
Etid klinik pou Kansè poumon selil ti nan Cleveland, OH
13 etid pou Kansè poumon selil ti ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Ap rekriteFaz 2
- University Hospitals Cleveland Medical Center /ID# 277556, Cleveland
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ap rekriteFaz 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Ap rekriteFaz 2/3
- University Hospitals Cleveland Medical Center, Cleveland
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Ap rekriteFaz 1/2
- University Hospitals Cleveland Medical Center, Cleveland
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
Ap rekriteFaz 1/2
- University Hospitals Cleveland Medical Center, Cleveland
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Ap rekriteFaz 3
- University Hospitals Cleveland Medical Center, Cleveland
- Cleveland Clinic - Fairview Hospital Molly Pavilion, Cleveland
- Cleveland Clinic, Cleveland
- ak 1 plis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Ap rekriteFaz 3
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic Cancer Center at Fairview Hospital, Moll Pavilion, Cleveland
- Cleveland Clinic Foundation, Cleveland
- ak 1 plis
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Ap rekriteFaz 1/2
- Cleveland Clinic Taussig Cancer Institute Case Comprehensive Cancer Center, Cleveland
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Ap rekriteFaz 2
- University Hospital - Cleveland Medical Center, Cleveland
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Ap rekriteFaz 2
- Cleveland Clinic, Cleveland
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
Ap rekriteFaz 1
- Case Comprehensive Cancer Center, Cleveland
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
Ap rekriteFaz 1
- Zelgen Site 104, Cleveland
Etid Kansè poumon selil ti nan lòt vil
- Houston, TX26 etid
- Arlington, VA23 etid
- Boston, MA21 etid
- New York City, NY21 etid
- Nashville, TN20 etid
- Los Angeles, CA20 etid
- Orlando, FL15 etid
- Dallas, TX13 etid
- St. Louis, MO13 etid
- Detroit, MI12 etid
- Chicago, IL12 etid
- Washington, DC12 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.